[HTML][HTML] The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …

[PDF][PDF] Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention

Z Khatoon, CD McTiernan, EJ Suuronen, TF Mah… - Heliyon, 2018 - cell.com
In living organisms, biofilms are defined as complex communities of bacteria residing within
an exopolysaccharide matrix that adheres to a surface. In the clinic, they are typically the …

[图书][B] Global report on infection prevention and control

World Health Organization - 2022 - books.google.com
Page 1 Healthsys temstr engthening Internationalh ealthre gulations Patient safety Quality im
provement O utbreakpr eparednessan dr esnopse C linicalca re and prevention Infection control …

[HTML][HTML] Inhaled amikacin to prevent ventilator-associated pneumonia

S Ehrmann, F Barbier, J Demiselle… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether preventive inhaled antibiotics may reduce the incidence of ventilator-
associated pneumonia is unclear. Methods In this investigator-initiated, multicenter, double …

Antibiotic resistance in Pseudomonas aeruginosa–Mechanisms, epidemiology and evolution

J Botelho, F Grosso, L Peixe - Drug resistance updates, 2019 - Elsevier
Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …

[HTML][HTML] Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence

MF Moradali, S Ghods, BHA Rehm - Frontiers in cellular and infection …, 2017 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic pathogen affecting immunocompromised
patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis (CF) …

[HTML][HTML] Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

[HTML][HTML] Rationalizing antimicrobial therapy in the ICU: a narrative review

JF Timsit, M Bassetti, O Cremer, G Daikos… - Intensive care …, 2019 - Springer
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections

JW Newman, RV Floyd… - FEMS microbiology letters, 2017 - academic.oup.com
Pseudomonas aeruginosa can cause complicated urinary tract infections, particularly in
people with catheters, which can lead to pyelonephritis. Whilst some subgroups appear …

[HTML][HTML] Assessment of knowledge and practices of healthcare workers towards infection prevention and associated factors in healthcare facilities of West Arsi District …

BS Geberemariyam, GM Donka, B Wordofa - Archives of Public Health, 2018 - Springer
Background The prevention of healthcare associated infections is central to the provision of
safe, high quality healthcare. Infections acquired in healthcare facilities are a major public …